204 related articles for article (PubMed ID: 11147808)
21. Genetic and epigenetic alterations of BRG1 promote oral cancer development.
Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N
Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241
[TBL] [Abstract][Full Text] [Related]
22. Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor gamma nuclear hormone receptor.
Salma N; Xiao H; Mueller E; Imbalzano AN
Mol Cell Biol; 2004 Jun; 24(11):4651-63. PubMed ID: 15143161
[TBL] [Abstract][Full Text] [Related]
23. c-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation function.
Cheng SW; Davies KP; Yung E; Beltran RJ; Yu J; Kalpana GV
Nat Genet; 1999 May; 22(1):102-5. PubMed ID: 10319872
[TBL] [Abstract][Full Text] [Related]
24. Mammalian SWI/SNF chromatin remodeling complexes are required to prevent apoptosis after DNA damage.
Park JH; Park EJ; Hur SK; Kim S; Kwon J
DNA Repair (Amst); 2009 Jan; 8(1):29-39. PubMed ID: 18822392
[TBL] [Abstract][Full Text] [Related]
25. A SWI/SNF-related chromatin remodeling complex, E-RC1, is required for tissue-specific transcriptional regulation by EKLF in vitro.
Armstrong JA; Bieker JJ; Emerson BM
Cell; 1998 Oct; 95(1):93-104. PubMed ID: 9778250
[TBL] [Abstract][Full Text] [Related]
26. BRG1 loss in MiaPaCa2 cells induces an altered cellular morphology and disruption in the organization of the actin cytoskeleton.
Rosson GB; Bartlett C; Reed W; Weissman BE
J Cell Physiol; 2005 Nov; 205(2):286-94. PubMed ID: 15887247
[TBL] [Abstract][Full Text] [Related]
27. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
[TBL] [Abstract][Full Text] [Related]
28. Brg1, the ATPase subunit of the SWI/SNF chromatin remodeling complex, is required for myeloid differentiation to granulocytes.
Vradii D; Wagner S; Doan DN; Nickerson JA; Montecino M; Lian JB; Stein JL; van Wijnen AJ; Imbalzano AN; Stein GS
J Cell Physiol; 2006 Jan; 206(1):112-8. PubMed ID: 15965950
[TBL] [Abstract][Full Text] [Related]
29. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing.
Harikrishnan KN; Chow MZ; Baker EK; Pal S; Bassal S; Brasacchio D; Wang L; Craig JM; Jones PL; Sif S; El-Osta A
Nat Genet; 2005 Mar; 37(3):254-64. PubMed ID: 15696166
[TBL] [Abstract][Full Text] [Related]
30. Inducible changes in cell size and attachment area due to expression of a mutant SWI/SNF chromatin remodeling enzyme.
Hill DA; Chiosea S; Jamaluddin S; Roy K; Fischer AH; Boyd DD; Nickerson JA; Imbalzano AN
J Cell Sci; 2004 Nov; 117(Pt 24):5847-54. PubMed ID: 15537831
[TBL] [Abstract][Full Text] [Related]
31. Reprogramming of the SWI/SNF complex for co-activation or co-repression in prohibitin-mediated estrogen receptor regulation.
Zhang B; Chambers KJ; Faller DV; Wang S
Oncogene; 2007 Nov; 26(50):7153-7. PubMed ID: 17486062
[TBL] [Abstract][Full Text] [Related]
32. BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer.
Rodriguez-Nieto S; Sanchez-Cespedes M
Carcinogenesis; 2009 Apr; 30(4):547-54. PubMed ID: 19176640
[TBL] [Abstract][Full Text] [Related]
33. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
[TBL] [Abstract][Full Text] [Related]
34. Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits.
Phelan ML; Sif S; Narlikar GJ; Kingston RE
Mol Cell; 1999 Feb; 3(2):247-53. PubMed ID: 10078207
[TBL] [Abstract][Full Text] [Related]
35. SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.
Watanabe R; Ui A; Kanno S; Ogiwara H; Nagase T; Kohno T; Yasui A
Cancer Res; 2014 May; 74(9):2465-75. PubMed ID: 24788099
[TBL] [Abstract][Full Text] [Related]
36. A role for BAF57 in cell cycle-dependent transcriptional regulation by the SWI/SNF chromatin remodeling complex.
Hah N; Kolkman A; Ruhl DD; Pijnappel WW; Heck AJ; Timmers HT; Kraus WL
Cancer Res; 2010 Jun; 70(11):4402-11. PubMed ID: 20460533
[TBL] [Abstract][Full Text] [Related]
37. The BRG1- and hBRM-associated factor BAF57 induces apoptosis by stimulating expression of the cylindromatosis tumor suppressor gene.
Wang L; Baiocchi RA; Pal S; Mosialos G; Caligiuri M; Sif S
Mol Cell Biol; 2005 Sep; 25(18):7953-65. PubMed ID: 16135788
[TBL] [Abstract][Full Text] [Related]
38. Maintenance of integrated proviral gene expression requires Brm, a catalytic subunit of SWI/SNF complex.
Mizutani T; Ito T; Nishina M; Yamamichi N; Watanabe A; Iba H
J Biol Chem; 2002 May; 277(18):15859-64. PubMed ID: 11850427
[TBL] [Abstract][Full Text] [Related]
39. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma.
Hornick JL; Dal Cin P; Fletcher CD
Am J Surg Pathol; 2009 Apr; 33(4):542-50. PubMed ID: 19033866
[TBL] [Abstract][Full Text] [Related]
40. SWI/SNF complexes and facilitation of TATA binding protein:nucleosome interactions.
Imbalzano AN
Methods; 1998 Aug; 15(4):303-14. PubMed ID: 9740718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
